HSBC Holdings
VYGR icon

HSBC Holdings’s Voyager Therapeutics VYGR Stock Holding History

HSBC Holdings’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Hold
33,202
– – ﹤0.01% 2788
2026
Q1 		$129K Sell
33,202
-19,434
-37% -$76.5K ﹤0.01% 2713
2025
Q4 		$206K Sell
52,636
-95,419
-64% -$422K ﹤0.01% 2680
2025
Q3 		$675K Sell
148,055
-322
-0.2% -$1.17K ﹤0.01% 1958
2025
Q2 		$440K Buy
148,377
+80,474
+119% +$260K ﹤0.01% 2213
2025
Q1 		$229K Buy
67,903
+28,878
+74% +$135K ﹤0.01% 2543
2024
Q4 		$220K Buy
39,025
+2,135
+6% +$13.8K ﹤0.01% 2665
2024
Q3 		$217K Buy
36,890
+20,650
+127% +$150K ﹤0.01% 2559
2024
Q2 		$128K Buy
+16,240
New +$136K ﹤0.01% 2687
2024
Q1 		– Sell
-14,322
Closed -$122K – 3255
2023
Q4 		$122K Buy
+14,322
New +$104K ﹤0.01% 2567

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HSBC Holdings's VYGR Position: Q2 2026 in Review

HSBC Holdings held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 33,202 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

HSBC Holdings first reported a position in VYGR in Q4 2023 and has held it in 10 quarters since. The position peaked at $675K in Q3 2025. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • HSBC Holdings held 33,202 shares of Voyager Therapeutics worth $117K as of Q2 2026.
  • HSBC Holdings left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2788 holding.
  • HSBC Holdings first reported a position in Voyager Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • HSBC Holdings's Voyager Therapeutics position peaked at $675K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.